Abstract:
The greatest proportion of Competitive Intelligence (CI) practice in the pharmaceutical industry is located within the R&D function (Halliday et al 1992). This paper reports on the results of an empirical study into the infrastructure of competitive intelligence practice within the industry. The study analyses and reports on the results from data and views gathered via questionnaire which addressed the questions of attitudes towards CI, methods of gathering CI, practitioner background, and problem areas.
